Prospective Randomized Study Comparing Sentinel Lymph Node Evaluation With Standard Pathologic Evaluation for the Staging of Colon Carcinoma: Results From the United States Military Cancer Institute Clinical Trials Group Study GI-01

Background:The principal role of sentinel lymph node (SLN) sampling and ultrastaging in colon cancer is enhanced staging accuracy. The utility of this technique for patients with colon cancer remains controversial. Purpose:This multicenter randomized trial was conducted to determine if focused assessment of the SLN with step sectioning and immunohistochemistry (IHC) enhances the ability to stage the regional nodal basin over conventional histopathology in patients with resectable colon cancer. Patients and Methods:Between August 2002 and April 2006 we randomly assigned 161 patients with stage I–III colon cancer to standard histopathologic evaluation or SLN mapping (ex vivo, subserosal, peritumoral, 1% isosulfan blue dye) and ultrastaging with pan-cytokeratin IHC in conjunction with standard histopathology. SLN-positive disease was defined as individual tumor cells or cell aggregates identified by hematoxylin and eosin (H&E) and/or IHC. Primary end point was the rate of nodal upstaging. Results:Significant nodal upstaging was identified with SLN ultrastaging (Control vs. SLN: 38.7% vs. 57.3%, P = 0.019). When SLNs with cell aggregates ≤0.2 mm in size were excluded, no statistically significant difference in node-positive rate was apparent between the control and SLN arms (38.7% vs. 39.0%, P = 0.97). However, a 10.7% (6/56) nodal upstaging was identified by evaluation of H&E stained step sections of SLNs among study arm patients who would have otherwise been staged node-negative (N0) by conventional pathologic assessment alone. Conclusion:SLN mapping, step sectioning, and immunohistochemistry (IHC) identifies small volume nodal disease and improves staging in patients with resectable colon cancer. A prospective trial is ongoing to determine the clinical significance of colon cancer micrometastasis in sentinel lymph nodes.

[1]  R. Glynne-Jones,et al.  The Role of Radiotherapy in the Treatment of Rectal Cancer , 2006 .

[2]  M. McCarter,et al.  Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. , 2006, Archives of surgery.

[3]  T. Beutler,et al.  A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. , 2006, American journal of surgery.

[4]  C. Compton,et al.  Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Potter,et al.  Colon sentinel lymph node mapping: practical surgical applications. , 2005, Journal of the American College of Surgeons.

[6]  T. Beutler,et al.  Comparative Analysis of Nodal Upstaging Between Colon and Rectal Cancers by Sentinel Lymph Node Mapping: A Prospective Trial , 2004, Diseases of the colon and rectum.

[7]  C. Compton,et al.  Sentinel Node Staging of Resectable Colon Cancer: Results of a Multicenter Study , 2004, Annals of surgery.

[8]  T. Namiki,et al.  Validation of Ex Vivo Lymphatic Mapping in Hematoxylin-Eosin Node-Negative Carcinoma of the Colon and Rectum , 2004, Annals of Surgical Oncology.

[9]  T. Beutler,et al.  Sentinel lymph node mapping technique in colon cancer. , 2004, Seminars in oncology.

[10]  K. Hunt,et al.  A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping , 2004, Cancer.

[11]  L. Terracciano,et al.  Identification of Sentinel Lymph Nodes in Colon Cancer Depends on the Amount of Dye Injected Relative to Tumor Size , 2003, World Journal of Surgery.

[12]  E. Fisher,et al.  Lack of Influence of Cytokeratin-Positive Mini Micrometastases in ”Negative Node” Patients With Colorectal Cancer: Findings From the National Surgical Adjuvant Breast and Bowel Projects Protocols R-01 and C-01 , 2003, Diseases of the colon and rectum.

[13]  P. Catalano,et al.  Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Waisberg,et al.  Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti‐cytokeratin antibodies AE1/AE3 , 2003, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[15]  L. Sobin,et al.  Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Paramo,et al.  Validation of sentinel node mapping in patients with colon cancer , 2002, Annals of Surgical Oncology.

[17]  S. Hong,et al.  Incidence and Prognostic Implications of Isolated Tumor Cells in Lymph Nodes from Patients with Dukes B Colorectal Carcinoma , 2002, Diseases of the colon and rectum.

[18]  R. Tollenaar,et al.  Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. , 2002, European journal of cancer.

[19]  S. Steinemann,et al.  Volume of lymphatic metastases does not independently influence prognosis in colorectal cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  R. Rosenberg,et al.  Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  K. Hunt,et al.  A caution regarding lymphatic mapping in patients with colon cancer. , 2001, American journal of surgery.

[22]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials , 2001, Annals of Internal Medicine.

[23]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[24]  D. Morton,et al.  Validation of Lymphatic Mapping in Colorectal Cancer: In Vivo, Ex Vivo, and Laparoscopic Techniques , 2001, Annals of Surgical Oncology.

[25]  R. Turner,et al.  Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Ahsan,et al.  Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma. , 2000, Archives of pathology & laboratory medicine.

[27]  C C Compton,et al.  Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. , 2000, Archives of pathology & laboratory medicine.

[28]  T. Beutler,et al.  Technical Details of Sentinel Lymph Node Mapping in Colorectal Cancer and Its Impact on Staging , 2000, Annals of Surgical Oncology.

[29]  S. Hirohashi,et al.  Clinical Implications of Lymph Node Micrometastases in Patients with Colorectal Cancers , 1999, Oncology.

[30]  R. Stenling,et al.  Are lymph node micrometastases of any clinical significance in dukes stages A and B colorectal cancer? , 1998, Diseases of the colon and rectum.

[31]  C. V. D. van de Velde,et al.  Micrometastases and survival in stage II colorectal cancer. , 1998, The New England journal of medicine.

[32]  R. Broll,et al.  Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas , 1997, Diseases of the colon and rectum.

[33]  L. Hakansson,et al.  Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. , 1996, The European journal of surgery = Acta chirurgica.

[34]  M. Ogawa,et al.  Genetic diagnosis of lymph-node metastasis in colorectal cancer , 1995, The Lancet.

[35]  M. Toner,et al.  The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma , 1994, The Journal of pathology.

[36]  J. Greenson,et al.  Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long‐term survival , 1994, Cancer.

[37]  V. Alves,et al.  Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins , 1991, Diseases of the colon and rectum.

[38]  N. Petrelli,et al.  Metastases in small lymph nodes from colon cancer. , 1987, Archives of surgery.

[39]  N. Petrelli,et al.  Clinical significance of colorectal cancer: Metastases in lymph nodes <5 mm in size , 2006, Annals of Surgical Oncology.